We are live on ! Find out more
AVA

Atlas Venture Advisors Portfolio holdings

AUM $122M
1-Year Est. Return 26.28%
This Fund
S&P 500
This Quarter Est. Return
+16.24%
1 Year Est. Return
-26.28%
3 Year Est. Return
-22.79%
5 Year Est. Return
-46.44%
10 Year Est. Return
–
AUM
$242M
AUM Growth
+$43.5M
Cap. Flow
+$16.4M
Cap. Flow %
6.79%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BCYC
Bicycle Therapeutics
BCYC
+$16.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 67.98%
2 Healthcare 30.57%
3 Communication Services 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBLK
1
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$164M 67.98%
9,823,103
– –
TBIO
2
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$49.5M 20.5%
3,922,008
– –
BCYC
3
Bicycle Therapeutics
BCYC
$270M
$13.7M 5.67%
+1,362,696
New +$16.4M
VRDN icon
4
Viridian Therapeutics
VRDN
$2.13B
$6.44M 2.67%
209,505
– –
LRMR icon
5
Larimar Therapeutics
LRMR
$416M
$4.17M 1.73%
292,184
– –
SNAP icon
6
Snap
SNAP
$7.32B
$3.5M 1.45%
245,076
– –

Similar funds

RCWM
Red Crane Wealth Management San Francisco, California $122M AUM 14.77% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SO
Sierra Ocean Ripon, California $122M AUM 16.19% 1-Year Est. Return
MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $122M AUM 362.1% 1-Year Est. Return
TCM
TT Capital Management Coto De Caza, California $121M AUM 1.94% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Atlas Venture Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Atlas Venture Advisors held 6 positions worth $242M, up 22% from $198M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Atlas Venture Advisors deployed $16.4M of net new capital in Q2 2019, opening 1 new position. Its largest new stake was Bicycle Therapeutics: 1,362,696 shares worth $13.7M.

By sector, the portfolio is most concentrated in Technology at 68% of assets, down from 69% a quarter earlier, followed by Healthcare and Communication Services.

  • Atlas Venture Advisors's largest Q2 2019 buy was Bicycle Therapeutics: 1,362,696 shares worth $13.7M.
  • Atlas Venture Advisors's ten largest holdings make up 100% of its $242M portfolio in Q2 2019.
  • Atlas Venture Advisors opened 1 new position and closed 0 in Q2 2019.
  • Atlas Venture Advisors's portfolio value rose 22% quarter-over-quarter to $242M.

Based on Atlas Venture Advisors's 13F filing for Q2 2019, filed 6 Aug 2019.